glp 1 agonists long term effects GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes

Comparative effectiveness of SGLT2 inhibitors, GLP 1 receptor agonists, DPP 4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records The Lancet GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly alcohol and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and substance intake, though Incretins: How we got here, where we're at and what is coming next DiabetesontheNet GLP 1 & SGLT2 Inhibitor Combination Therapy Bolt Pharmacy Perioperative Management of GLP 1 Receptor Agonists: Balancing Aspiration Risk with Therapeutic Benefit SN Comprehensive Clinical Medicine Springer Nature Link The Multifaceted Nature of GLP 1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases